Magenta CSO Michael Cooke jumps to IFM Therapeutics by Amirah Al Idrus Tuesday, January 7, 2020 Fresh off a $55.5 million round, IFM Therapeutics snagged a new chief scientific officer. Michael Cooke, Ph.D., joins from stem cell biotech Magenta.
IFM gets new CEO, bags another $55M to launch incubator by Amirah Al Idrus Monday, December 2, 2019 IFM Therapeutics promoted its R&D chief Martin Seidel, Ph.D., to CEO and reeled in $55.5 million to fund more subsidiaries, including an incubator.
